Drug pricing

News

House Oversight Committee chair James Comer (r)

PBMs will face House committee grilling next week

The House Committee on Oversight and Accountability will quiz leaders of pharmacy benefit managers (PBMs) at a hearing next week, amid scrutiny of the sector's role in rising healthcare cos

News

Germany inches closer to confidential pricing for drugs

Pharma companies who want to keep the prices of their medicines private in Germany may soon be able to do so – as long as they meet certain conditions.

News

Bill that would cut down ‘patent thickets’ clears Senate

The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors.

News

FTC said to be planning legal action against PBMs

The Federal Trade Commission in the US is planning to sue the owners of the three largest pharmacy benefits managers (PBMs) for anti-competitive behaviour, on the heels of its damning repor

News

FTC report finds PBM power has “dire consequences”

A long-awaited report from the US Federal Trade Commission (FTC) on pharmacy benefit managers (PBMs) is out – and will make uncomfortable reading for the pharma supply chain middlemen.

News

Judge kicks out another Medicare price negotiation challenge

A Connecticut federal judge has sided with the US Department of Health and Human Services (HHS) in Boehringer Ingelheim's challenge to Medicare’s drug price negotiation programme, rejecting

PBMs will face House committee grilling next week

Germany inches closer to confidential pricing for drugs

Bill that would cut down ‘patent thickets’ clears Senate

FTC said to be planning legal action against PBMs

FTC report finds PBM power has “dire consequences”

Judge kicks out another Medicare price negotiation challenge

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

Drug pricing

Editor's Picks